LOAN AGREEMENT and PROMISSORY NOTELoan Agreement • April 2nd, 2019 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
DATE: 5th December 2018 CONTRACT RELATING TO SALE OF SPICERS, SAWSTON, CAMBRIDGE Between ARACARIS CAPITAL LIMITED and HUAWEI TECHNOLOGIES RESEARCH & DEVELOPMENT (UK) LIMITEDAsset Sale Contract • April 2nd, 2019 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • England and Wales
LEASE RELATING TO VISION CENTRE, SAWSTON, CAMBRIDGE Dated: 14 December 2018 Between ARACARIS CAPITAL LIMITED and ARACARIS LIMITED CMS Cameron McKenna Nabarro Olswang LLP Cannon Place 78 Cannon Street London EC4N 6AF T +44 20 7367 3000 F +44 20 7367...Northwest Biotherapeutics Inc • April 2nd, 2019 • Pharmaceutical preparations • England and Wales
and in this definition “Landlord” means the group of undertakings of which the Landlord is a Se member for the purposes of such allowances or taxes;
SETTLEMENT AND AMENDMENT AGREEMENTSettlement and Amendment Agreement • April 2nd, 2019 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
THIS SETTLEMENT AND AMENDMENT AGREEMENT (this “Agreement”) is made and entered into as of December 31, 2017 (the “Effective Date”), by and between Cognate BioServices, Inc., a Delaware corporation (“Cognate”) and Northwest Biotherapeutics, Inc., a Delaware corporation (“NWBio” and together with Cognate, the “Parties”).
FORM OF UNSECURED PROMISSORY NOTE AGREEMENT PLUS WARRANTNorthwest Biotherapeutics Inc • April 2nd, 2019 • Pharmaceutical preparations • New York
FOR VALUE RECEIVED, Northwest Biotherapeutics, Inc. (the “Company”) promises to pay to the order of and his authorized successors and permitted assigns (“Holder”), the aggregate principal face amount of Dollars (U.S. $ ) on November 7th, 2019 (“Maturity Date”), including a 5% Original Issue Discount (“OID”) of Dollars ($ ), and to accrue interest on the principal amount outstanding hereunder at the rate of 10% per annum commencing on November 7, 2018. Upon execution of the Note, Holder shall wire to the Company $ . The principal of, and interest on, this Note are payable at the address or wire account of the Holder last appearing on the records of the Company as designated in writing by the Holder hereof from time to time. The Company will pay all interest payments and the outstanding principal due upon this Note before or on the Maturity Date, less any amounts required by law to be deducted or withheld, to the Holder of this Note by check or wire transfer addressed to· ·such Holder at
